- Home
- JMM vs ONCY Comparison
JMM vs ONCY Comparison
Compare JMM & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMM
- ONCY
- Stock Information
- Founded
- JMM 1988
- ONCY 1998
- Country
- JMM United States
- ONCY Canada
- Employees
- JMM N/A
- ONCY N/A
- Industry
- JMM Trusts Except Educational Religious and Charitable
- ONCY Pharmaceuticals and Biotechnology
- Sector
- JMM Finance
- ONCY Health Care
- Exchange
- JMM Nasdaq
- ONCY Nasdaq
- Market Cap
- JMM 58.2M
- ONCY 49.2M
- IPO Year
- JMM N/A
- ONCY 1999
- Fundamental
- Price
- JMM $6.04
- ONCY $0.56
- Analyst Decision
- JMM
- ONCY Strong Buy
- Analyst Count
- JMM 0
- ONCY 3
- Target Price
- JMM N/A
- ONCY $4.33
- AVG Volume (30 Days)
- JMM 16.1K
- ONCY 330.3K
- Earning Date
- JMM 01-01-0001
- ONCY 05-08-2025
- Dividend Yield
- JMM 5.44%
- ONCY N/A
- EPS Growth
- JMM N/A
- ONCY N/A
- EPS
- JMM N/A
- ONCY N/A
- Revenue
- JMM N/A
- ONCY N/A
- Revenue This Year
- JMM N/A
- ONCY N/A
- Revenue Next Year
- JMM N/A
- ONCY N/A
- P/E Ratio
- JMM N/A
- ONCY N/A
- Revenue Growth
- JMM N/A
- ONCY N/A
- 52 Week Low
- JMM $5.29
- ONCY $0.47
- 52 Week High
- JMM $6.10
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- JMM 48.95
- ONCY 45.75
- Support Level
- JMM $5.83
- ONCY $0.47
- Resistance Level
- JMM $5.96
- ONCY $0.65
- Average True Range (ATR)
- JMM 0.14
- ONCY 0.05
- MACD
- JMM -0.01
- ONCY 0.01
- Stochastic Oscillator
- JMM 58.06
- ONCY 50.00
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.